Experimental peptide that affects bacterial biofilm stress responses
Preclinical research
Read the profile Peptide profile
KPV
Also known as Lys-Pro-Val
Alpha-MSH fragment studied in inflammatory signaling
Preclinical research
Science, with its context intact.What to knowThe evidence
The evidence
in perspective.
The cited study tested nanoparticle-delivered KPV in experimental colitis. Animal findings and formulation-specific effects do not demonstrate effectiveness in human bowel disease.
View the supporting source- Research area
- Immune
- Biological target or mechanism
- Alpha-MSH fragment studied in inflammatory signaling
- Evidence context
- Preclinical research
- Availability
- Availability requires pharmacy review
From information to a conversationClinical decisions stay
Clinical decisions stay
with clinical professionals.
This profile is a research reference. Your prescriber and pharmacy assess the relevant clinical and dispensing pathway. Inclusion here is not an offer to sell this compound.
Explore the same area.
All immune profiles
Human cathelicidin peptide with antimicrobial and immune-signaling activity
Clinical research
Read the profile 